ArticleClinical drug investigation2024

Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.

Ryan Thaliffdeen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.